MRD Testing in Multiple Myeloma: From a Surrogate Marker of Clinical Outcomes to an Every-Day Clinical Tool

Overview of attention for article published in Seminars in Hematology (ScienceDirect), March 2018

Altmetric Badge

About this Attention Score

In the top 25% of all research outputs scored by Altmetric
Among the highest-scoring outputs from this source (#32 of 1,017)
High Attention Score compared to outputs of the same age (90th percentile)
High Attention Score compared to outputs of the same age and source (94th percentile)

Mentioned by

news: 1 news outlet
twitter: 14 X users
patent: 6 patents

facebook: 1 Facebook page
guideline: 1 clinical guideline source

Readers on

mendeley: 26 Mendeley

So far, Altmetric has seen 6 patents that reference this research output.

Alvocidib prodrugs having increased bioavailability

Grant US-12338261-B2

United States of America

24 Jun 2025

CDK9 inhibitors and polymorphs thereof for use as agents for treatment of cancer

Grant US-12077554-B2

United States of America

03 Sep 2024

Treatment of acute myeloid leukemia (AML) with venetoclax failure

Grant US-11793802-B2

United States of America

24 Oct 2023

CDK9 inhibitors and polymorphs thereof for use as agents for treatment of cancer

Grant US-11530231-B2

United States of America

20 Dec 2022

This page shows the most recent patents that mention this research output. Click here to find out how to access more activity, including 2 additional patents.